Evaluation of the Predictive Value of Her-2/neu Overexpression and p53 Mutations in High-Risk Primary Breast Cancer Patients Treated With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

Yago Nieto(The University of Texas MD Anderson Cancer Center), Roy B. Jones(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Janet McDermit(University of Colorado Boulder), Ronit Yerushalmi(University of Colorado Boulder), Samia Nawaz(University of Colorado Boulder), Peggy Russell(University of Colorado Hospital), James R. Murphy(University of Liverpool), Scott I. Bearman(University of Washington), Pablo J. Cagnoni(University of Colorado Hospital), Bret Cook(University of Colorado Boulder)
Journal of Clinical Oncology
May 10, 2000
Cited by 62


Related Papers